Open AccessHow Many Nodes Need to be Removed to Make Esophagectomy an Adequate Cancer Operation, and Does the Number Change When a Patient has Chemoradiotherapy Before Surgery?
Author(s) -
Jonathan C. Yeung,
Manjit S. Bains,
Arianna Barbetta,
Tamar Nobel,
Steven R. DeMeester,
Brian E. Louie,
Mark B. Orringer,
Linda W. Martin,
Rishindra M. Reddy,
Francisco Schlottmann,
Daniela Molena
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-07870-2
Subject(s) - medicine , surgical oncology , esophagectomy , esophageal cancer , chemoradiotherapy , dissection (medical) , stage (stratigraphy) , lymph node , surgery , general surgery , cancer , radiation therapy , paleontology , biology
Node dissection during esophagectomy is an important aspect of esophageal cancer staging. Controversy remains as to how many nodes need to be resected in order to properly stage a patient and whether the removal of more nodes carries a stage-independent survival benefit. A review of the literature performed by a group of experts in the subject may help define a minimum accepted number of lymph nodes to be resected in both primary surgery and post-induction therapy scenarios.